hydroxyflutamide has been researched along with Bladder Cancer in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chuang, KH; Ide, H; Inoue, S; Jiang, G; Miyamoto, H; Mizushima, T; Oya, M | 1 |
Chang, C; Han, R; Li, Y; Messing, E; Niu, Y; Shang, Z; Shyr, CR; Tian, J; Yeh, S; Zhang, M | 1 |
El-Shishtawy, KA; Ide, H; Kashiwagi, E; Kawahara, T; Li, Y; Miyamoto, H; Reis, LO; Zheng, Y | 1 |
Chang, C; Hsu, JW; Izumi, K; Miyamoto, H; Zheng, Y | 1 |
4 other study(ies) available for hydroxyflutamide and Bladder Cancer
Article | Year |
---|---|
Androgen Receptor Signaling Reduces Radiosensitivity in Bladder Cancer.
Topics: Androgen Receptor Antagonists; Animals; Cell Line, Tumor; Cell Proliferation; DNA Breaks, Double-Stranded; DNA Repair; Flutamide; Humans; Mice; Radiation Tolerance; Radiation, Ionizing; Receptors, Androgen; Signal Transduction; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2018 |
Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression.
Topics: Androgen Antagonists; Animals; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cell Line, Tumor; Cell Movement; Cell Survival; Curcumin; Disease Progression; Drug Synergism; Female; Flutamide; Gene Expression; Humans; Integrin alpha5beta1; Interleukin-6; Macrophages; Mice; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Urinary Bladder Neoplasms | 2015 |
Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth.
Topics: Androgen Antagonists; Anilides; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dihydrotestosterone; Down-Regulation; Flutamide; Humans; Interleukin-6; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Nitriles; Phenylthiohydantoin; Receptors, Androgen; RNA; Tosyl Compounds; Transcription, Genetic; Urinary Bladder Neoplasms | 2016 |
Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Animals; Cell Line; Cystectomy; Dihydrotestosterone; Down-Regulation; Female; Flutamide; Follow-Up Studies; Gene Expression Regulation, Enzymologic; Glucuronosyltransferase; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Orchiectomy; Receptors, Androgen; Reference Values; Signal Transduction; UDP-Glucuronosyltransferase 1A9; Urinary Bladder; Urinary Bladder Neoplasms | 2013 |